ANI Pharmaceuticals Overview
ANI Pharmaceuticals Target Price
Analysts' 12-month price predictions for ANIP.
Get informed when a big investor buys or sells
+ FollowShare Price
$82.29
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-01-16 | GuggenheimVamil Divan | $124 |  50.7% upside |  |
| 2025-10-09 | Truist Financial | $90 | 9.4% upside | |
| 2025-09-17 | H.C. WainwrightBrandon Folkes | $121 | 47% upside | |
| 2025-09-08 | GuggenheimVamil Divan | $114 | 38.5% upside | |
| 2025-08-08 | Piper SandlerDavid Amsellem | $94 | 14.2% upside | |
| 2025-03-05 | Guggenheim | $86 | 4.5% upside | |
| 2024-09-18 | Raymond JamesGary Nachman | $83 | 0.9% upside | |
| 2024-09-11 | Truist FinancialLes Sulewski | $60 |  27.1% downside | |
| 2024-06-26 | H.C. WainwrightOren Livnat | $94 | 14.2% upside | |
| 2024-05-13 | H.C. WainwrightOren Livnat | $87 | 5.7% upside | |
| 2022-08-09 | Raymond James | $48 | 41.7% downside | |